Wang, Hao <br/><br/>
Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study.  [electronic resource] 

 -  The Clinical journal of pain  02 2017 
 - 99-108 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1536-5409 
<br/><br/><label>Standard No.: </label>10.1097/AJP.0000000000000388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analgesics--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuralgia, Postherpetic--drug therapy<br/>Pain Measurement<br/>Subcutaneous Absorption<br/>Treatment Failure<br/>Young Adult